by Siro Solutions Dev | Sep 19, 2024
Amir Zamani is a Managing Director at Bain Capital Life Sciences and leads investments in biopharmaceutical, medical device, and diagnostics companies. He currently serves as a board observer at Rivus Pharmaceuticals. He previously served as a board member at Aiolos...
by Siro Solutions Dev | Sep 11, 2024
Ron Renaud is Kailera’s President and Chief Executive Officer. Prior to joining Kailera, Ron served as Cerevel Therapeutics’ President and Chief Executive Officer, where he guided the company through significant milestones, culminating in its acquisition by...
by Siro Solutions Dev | Sep 11, 2024
Michael Gladstone is a partner at Atlas Venture and focuses on building new therapeutics companies. Michael is a co-founder and board member of Diagonal Therapeutics and Third Harmonic Bio (NASDAQ: THRD), and a board member of Day One Biopharmaceuticals (NASDAQ:...
by Siro Solutions Dev | Sep 11, 2024
Mr. Cozean is a Managing Director of Bain Capital Life Sciences, which he joined in 2013. He was previously a part of the North American Private Equity team in the Healthcare Vertical. Mr. Cozean is a Board Director for Seran Biosciences and a Board Observer for...
by Siro Solutions Dev | Sep 11, 2024
John F. Milligan, PhD, is Kailera’s Board Chair. John joined Gilead Sciences as the 32nd employee in 1990 and had a 29-year career with the company, retiring as President and Chief Executive Officer in December 2018. During his tenure at Gilead, he led teams that...
